Recently, Kobayashi Pharmaceutical Co., Ltd., a well-known Japanese pharmaceutical company, said that some consumers had health problems in kidney and other aspects after taking the health products containing red yeast rice ingredients produced by the company, and the company carried out an emergency recall of 3 products containing related ingredients. The company said on the 25th that 33 people have developed kidney disease and other conditions after taking health products containing red yeast rice, and 26 of them have been hospitalized.
Previously reported: Immediately deactivated!Kobayashi Pharmaceutical emergency recall!Available in China......
Consumers suffer from kidney disease and even need dialysis
Kobayashi Pharmaceutical said red yeast rice contained an unknown ingredient
On the 22nd local time, Japan's Kobayashi Pharmaceutical Company issued a notice on its official website that some consumers have recently developed diseases of the kidneys and other parts after using the health products containing red yeast rice ingredients produced by the company, and some patients have been hospitalized, and some even need dialysis.
Kobayashi Pharmaceutical said that after analyzing the composition of red yeast rice health products, it was found that some of the red yeast rice raw materials may contain unknown ingredients beyond the company's grasp.
△ Kobayashi Pharmaceutical: A health care product containing red yeast rice
Kobayashi Pharmaceutical said that it is still inconclusive whether there is a correlation between this unknown ingredient and consumers' illness, but in order to prevent the further expansion of the damage to consumers' health, Kobayashi Pharmaceutical has decided to recall three products containing red yeast rice ingredients and call on consumers to stop taking these three products immediately.
According to Kyodo News, "red koji cholesterol granules" have been sold in e-commerce channels and stores since February 2021, and about 1.06 million bags have been sold by the end of February this year.
On the 25th, Japan's Kobayashi Pharmaceutical Co., Ltd. announced that 33 people have developed kidney disease and other health abnormalities after taking the company's health products containing red yeast rice, and 26 of them have been hospitalized.
Advertise red yeast rice as promising to lower cholesterol
The products have been removed from the shelves of the official domestic online store
Kobayashi Pharmaceutical is a well-established Japanese pharmaceutical company with a history of more than 100 years. According to the company, red yeast rice is a raw material produced by fermentation of steamed rice mixed with monascus bacteria. The company advertises the ingredient as promising to lower LDL cholesterol levels.
Many of the products produced by Kobayashi Pharmaceutical are quite popular, and there are official stores of Kobayashi Pharmaceutical on many e-commerce platforms in China.
On March 22, Kobayashi Pharmaceutical issued the "Notice on Stopping the Use of Red Koji Cholesterol Granules and Self-Recall" on the official account of the social platform, reminding consumers who hold red koji cholesterol granules (60 capsules, barcode 4987072059708) to stop consuming them.
Up to now, red koji cholesterol granules have been removed from the shelves of the official store of Kobayashi Pharmaceutical, the e-commerce platform mentioned in the notice.
△ Kobayashi Pharmaceutical issued a notice on its official account on social platforms
8% of red yeast rice is sold to the outside world
A number of companies in Japan have announced product recalls
After Kobayashi Pharmaceutical announced an emergency recall of related products, various Japanese food and alcohol manufacturers announced the recall of red yeast rice-related products containing Kobayashi Pharmaceutical.
On the 24th, Nippon Takashi Sake Brewery Co., Ltd. announced that it had decided to independently recall about 96,000 bottles of the product because one of the wines produced by the company used red yeast rice raw materials provided by Kobayashi Pharmaceutical Co., Ltd. There are currently no reports of health damage related to this product from Takazo.
Wine manufacturers said that the wine was only exported to Singapore and Taiwan, China, and did not enter the Chinese mainland market.
According to Japanese media reports, about 20% of the red yeast rice produced by Kobayashi Pharmaceutical Company is used by the company, and the remaining about 80% is sold as raw materials to food production companies. The company's red yeast rice raw materials are sold to about 50 food and beverage manufacturers, among others.
The president of Kobayashi Pharmaceutical apologized
Acknowledging slow decision-making
△On March 22, the president of Kobayashi Pharmaceutical attended the press conference and bowed and apologized.
On the evening of the 22nd, the president of Kobayashi Pharmaceutical held a press conference to bow and apologize for the issue.
According to Japanese media reports, the analysis results on the 16th of this month have shown that some red yeast rice raw materials may contain unknown ingredients, but the company did not announce a recall until the 22nd. In this regard, the president of Kobayashi Pharmaceutical admitted that decision-making was slow.
Source: CCTV news client
The copyright belongs to the original author, and it pays tribute to the original